

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 6.09097384 |
| 2 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 5.94120062 |
| 3 | UMP metabolic process (GO:0046049) | 5.94120062 |
| 4 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 5.94120062 |
| 5 | UMP biosynthetic process (GO:0006222) | 5.94120062 |
| 6 | organic cation transport (GO:0015695) | 5.86214813 |
| 7 | drug transmembrane transport (GO:0006855) | 5.51273969 |
| 8 | nucleotide salvage (GO:0043173) | 5.40591915 |
| 9 | histamine transport (GO:0051608) | 5.26691415 |
| 10 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 5.03721904 |
| 11 | quaternary ammonium group transport (GO:0015697) | 4.79322443 |
| 12 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 4.76743900 |
| 13 | positive regulation of meiosis (GO:0045836) | 4.62189140 |
| 14 | exogenous drug catabolic process (GO:0042738) | 4.57909386 |
| 15 | viral transcription (GO:0019083) | 4.57661420 |
| 16 | pyrimidine nucleoside salvage (GO:0043097) | 4.54442736 |
| 17 | pyrimidine-containing compound salvage (GO:0008655) | 4.54442736 |
| 18 | nucleoside salvage (GO:0043174) | 4.50846622 |
| 19 | translational termination (GO:0006415) | 4.41217468 |
| 20 | positive regulation of meiotic cell cycle (GO:0051446) | 4.33533239 |
| 21 | resolution of meiotic recombination intermediates (GO:0000712) | 4.31971257 |
| 22 | detection of chemical stimulus involved in sensory perception of smell (GO:0050911) | 4.20518489 |
| 23 | translational elongation (GO:0006414) | 4.16282106 |
| 24 | neurotransmitter biosynthetic process (GO:0042136) | 4.12594587 |
| 25 | meiotic chromosome segregation (GO:0045132) | 4.12189617 |
| 26 | regulation of activation of Janus kinase activity (GO:0010533) | 4.07797976 |
| 27 | rRNA catabolic process (GO:0016075) | 4.07370908 |
| 28 | regulation of meiosis I (GO:0060631) | 3.98458783 |
| 29 | CTP metabolic process (GO:0046036) | 3.93830492 |
| 30 | CTP biosynthetic process (GO:0006241) | 3.93830492 |
| 31 | tooth mineralization (GO:0034505) | 3.91868327 |
| 32 | drug transport (GO:0015893) | 3.89680512 |
| 33 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.86652781 |
| 34 | drug catabolic process (GO:0042737) | 3.76841628 |
| 35 | pentose metabolic process (GO:0019321) | 3.74590076 |
| 36 | neurotransmitter metabolic process (GO:0042133) | 3.69234531 |
| 37 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 3.66862969 |
| 38 | behavioral response to nicotine (GO:0035095) | 3.65994855 |
| 39 | synaptonemal complex assembly (GO:0007130) | 3.60614861 |
| 40 | reciprocal meiotic recombination (GO:0007131) | 3.57176378 |
| 41 | reciprocal DNA recombination (GO:0035825) | 3.57176378 |
| 42 | ribosomal large subunit biogenesis (GO:0042273) | 3.54800085 |
| 43 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 3.53397049 |
| 44 | cellular ketone body metabolic process (GO:0046950) | 3.48424459 |
| 45 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.44588481 |
| 46 | pyrimidine ribonucleoside biosynthetic process (GO:0046132) | 3.37736764 |
| 47 | piRNA metabolic process (GO:0034587) | 3.37601188 |
| 48 | synaptonemal complex organization (GO:0070193) | 3.35872563 |
| 49 | cotranslational protein targeting to membrane (GO:0006613) | 3.35278036 |
| 50 | azole transport (GO:0045117) | 3.33598738 |
| 51 | protein targeting to ER (GO:0045047) | 3.31437707 |
| 52 | regulation of guanylate cyclase activity (GO:0031282) | 3.31387730 |
| 53 | protein localization to endoplasmic reticulum (GO:0070972) | 3.30197209 |
| 54 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.28370235 |
| 55 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.28370235 |
| 56 | cellular protein complex disassembly (GO:0043624) | 3.18075622 |
| 57 | pyrimidine ribonucleotide biosynthetic process (GO:0009220) | 3.16957728 |
| 58 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.14937111 |
| 59 | regulation of immune response to tumor cell (GO:0002837) | 3.14793271 |
| 60 | regulation of response to tumor cell (GO:0002834) | 3.14793271 |
| 61 | positive regulation of response to tumor cell (GO:0002836) | 3.14793271 |
| 62 | positive regulation of immune response to tumor cell (GO:0002839) | 3.14793271 |
| 63 | viral life cycle (GO:0019058) | 3.13258983 |
| 64 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.12497945 |
| 65 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.12194549 |
| 66 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.12003457 |
| 67 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.11425551 |
| 68 | ketone body metabolic process (GO:1902224) | 3.10167774 |
| 69 | detection of chemical stimulus involved in sensory perception (GO:0050907) | 3.08205000 |
| 70 | positive regulation of protein homodimerization activity (GO:0090073) | 3.07282503 |
| 71 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.05215925 |
| 72 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 3.03396528 |
| 73 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 3.01474533 |
| 74 | pentose-phosphate shunt (GO:0006098) | 3.01396118 |
| 75 | keratinocyte development (GO:0003334) | 3.00053628 |
| 76 | chromosome organization involved in meiosis (GO:0070192) | 2.96041931 |
| 77 | translational initiation (GO:0006413) | 2.94683986 |
| 78 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.93655536 |
| 79 | cornea development in camera-type eye (GO:0061303) | 2.92325576 |
| 80 | pyrimidine ribonucleotide metabolic process (GO:0009218) | 2.86297214 |
| 81 | activation of NF-kappaB-inducing kinase activity (GO:0007250) | 2.84553367 |
| 82 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.83250719 |
| 83 | negative regulation of telomere maintenance (GO:0032205) | 2.81297616 |
| 84 | response to nitric oxide (GO:0071731) | 2.80098254 |
| 85 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.79410588 |
| 86 | pyrimidine ribonucleoside metabolic process (GO:0046131) | 2.78347613 |
| 87 | negative regulation of epidermis development (GO:0045683) | 2.77122893 |
| 88 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 2.74743072 |
| 89 | carnitine transmembrane transport (GO:1902603) | 2.72975312 |
| 90 | fucose catabolic process (GO:0019317) | 2.71593608 |
| 91 | L-fucose metabolic process (GO:0042354) | 2.71593608 |
| 92 | L-fucose catabolic process (GO:0042355) | 2.71593608 |
| 93 | purine nucleotide salvage (GO:0032261) | 2.68666621 |
| 94 | maturation of SSU-rRNA (GO:0030490) | 2.68335703 |
| 95 | NADPH regeneration (GO:0006740) | 2.63719470 |
| 96 | synapsis (GO:0007129) | 2.62962397 |
| 97 | protein complex disassembly (GO:0043241) | 2.60229551 |
| 98 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.59486666 |
| 99 | histone H3-K36 demethylation (GO:0070544) | 2.59256118 |
| 100 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.58906957 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.39350097 |
| 2 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.78533810 |
| 3 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.78146014 |
| 4 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.89655573 |
| 5 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.70556781 |
| 6 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.59954278 |
| 7 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.52402666 |
| 8 | VDR_22108803_ChIP-Seq_LS180_Human | 2.46543304 |
| 9 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 2.34474136 |
| 10 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.13616654 |
| 11 | EWS_26573619_Chip-Seq_HEK293_Human | 2.08085667 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.00515340 |
| 13 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.96363581 |
| 14 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.90929797 |
| 15 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.90407188 |
| 16 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.85300320 |
| 17 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.82616907 |
| 18 | FUS_26573619_Chip-Seq_HEK293_Human | 1.82431208 |
| 19 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.81750536 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.81342587 |
| 21 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.74973130 |
| 22 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.73381681 |
| 23 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.72074781 |
| 24 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.68169899 |
| 25 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.68169899 |
| 26 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.68161883 |
| 27 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.61219365 |
| 28 | NCOR_22424771_ChIP-Seq_293T_Human | 1.57259778 |
| 29 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.55830500 |
| 30 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.55429736 |
| 31 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.53991435 |
| 32 | AR_20517297_ChIP-Seq_VCAP_Human | 1.52312884 |
| 33 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.47656413 |
| 34 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.44221423 |
| 35 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.41841418 |
| 36 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.41841418 |
| 37 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.41147086 |
| 38 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.37332770 |
| 39 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.37245256 |
| 40 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.36351979 |
| 41 | P300_19829295_ChIP-Seq_ESCs_Human | 1.34310578 |
| 42 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.31460426 |
| 43 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.31290970 |
| 44 | ERA_21632823_ChIP-Seq_H3396_Human | 1.28185987 |
| 45 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.24811346 |
| 46 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23979575 |
| 47 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.23943904 |
| 48 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.23049939 |
| 49 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.22209397 |
| 50 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.21096020 |
| 51 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.20673858 |
| 52 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.20105738 |
| 53 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.19802562 |
| 54 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.19309966 |
| 55 | GATA3_26560356_Chip-Seq_TH2_Human | 1.18277893 |
| 56 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.18018656 |
| 57 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.17479590 |
| 58 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.15681883 |
| 59 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.14964542 |
| 60 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.14475634 |
| 61 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.13682650 |
| 62 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.12544710 |
| 63 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.10403276 |
| 64 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.09213295 |
| 65 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.08099365 |
| 66 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07782304 |
| 67 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.07434223 |
| 68 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.07161898 |
| 69 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.06699501 |
| 70 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.06401807 |
| 71 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.06185175 |
| 72 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05658193 |
| 73 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.05601355 |
| 74 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.05293293 |
| 75 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.04976058 |
| 76 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.04710752 |
| 77 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.04407481 |
| 78 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.04276802 |
| 79 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.04141369 |
| 80 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.03672284 |
| 81 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.03252129 |
| 82 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.03252129 |
| 83 | TCF4_23295773_ChIP-Seq_U87_Human | 1.03161777 |
| 84 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.02572213 |
| 85 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.02360165 |
| 86 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.01507258 |
| 87 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.00622490 |
| 88 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.00238746 |
| 89 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.99451092 |
| 90 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.98897974 |
| 91 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.98453269 |
| 92 | JUN_21703547_ChIP-Seq_K562_Human | 0.98317815 |
| 93 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.97572613 |
| 94 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.97470240 |
| 95 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.97360545 |
| 96 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.96548673 |
| 97 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.95685373 |
| 98 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.94455480 |
| 99 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.94382988 |
| 100 | GATA3_26560356_Chip-Seq_TH1_Human | 0.93916535 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 4.81383546 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 4.57301663 |
| 3 | MP0009379_abnormal_foot_pigmentation | 4.52347481 |
| 4 | MP0001873_stomach_inflammation | 3.16059636 |
| 5 | MP0002163_abnormal_gland_morphology | 2.99297655 |
| 6 | MP0006292_abnormal_olfactory_placode | 2.93273665 |
| 7 | MP0005360_urolithiasis | 2.71988369 |
| 8 | MP0008872_abnormal_physiological_respon | 2.55856195 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 2.39853203 |
| 10 | MP0002160_abnormal_reproductive_system | 2.18108518 |
| 11 | MP0000372_irregular_coat_pigmentation | 2.01599478 |
| 12 | MP0005167_abnormal_blood-brain_barrier | 1.96107349 |
| 13 | MP0005389_reproductive_system_phenotype | 1.95795069 |
| 14 | MP0001919_abnormal_reproductive_system | 1.94894170 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 1.93153321 |
| 16 | MP0008877_abnormal_DNA_methylation | 1.91900834 |
| 17 | MP0002837_dystrophic_cardiac_calcinosis | 1.90764469 |
| 18 | MP0001986_abnormal_taste_sensitivity | 1.85055905 |
| 19 | MP0004043_abnormal_pH_regulation | 1.79237764 |
| 20 | MP0001664_abnormal_digestion | 1.76585675 |
| 21 | MP0002234_abnormal_pharynx_morphology | 1.74583545 |
| 22 | MP0005085_abnormal_gallbladder_physiolo | 1.73638075 |
| 23 | MP0005645_abnormal_hypothalamus_physiol | 1.70687925 |
| 24 | MP0004147_increased_porphyrin_level | 1.69135422 |
| 25 | MP0002102_abnormal_ear_morphology | 1.64496000 |
| 26 | MP0005379_endocrine/exocrine_gland_phen | 1.63893815 |
| 27 | MP0001835_abnormal_antigen_presentation | 1.57413056 |
| 28 | MP0002139_abnormal_hepatobiliary_system | 1.53386460 |
| 29 | MP0005551_abnormal_eye_electrophysiolog | 1.51791599 |
| 30 | MP0006276_abnormal_autonomic_nervous | 1.51652098 |
| 31 | MP0003718_maternal_effect | 1.49143343 |
| 32 | MP0005084_abnormal_gallbladder_morpholo | 1.48455036 |
| 33 | MP0001764_abnormal_homeostasis | 1.48058798 |
| 34 | MP0004885_abnormal_endolymph | 1.42687900 |
| 35 | MP0004145_abnormal_muscle_electrophysio | 1.41016344 |
| 36 | MP0002148_abnormal_hypersensitivity_rea | 1.40371724 |
| 37 | MP0006082_CNS_inflammation | 1.36807840 |
| 38 | MP0005075_abnormal_melanosome_morpholog | 1.31674563 |
| 39 | MP0001188_hyperpigmentation | 1.28737497 |
| 40 | MP0001663_abnormal_digestive_system | 1.27491836 |
| 41 | MP0005365_abnormal_bile_salt | 1.25812423 |
| 42 | MP0003724_increased_susceptibility_to | 1.24956710 |
| 43 | MP0000427_abnormal_hair_cycle | 1.24706371 |
| 44 | MP0003567_abnormal_fetal_cardiomyocyte | 1.24065373 |
| 45 | MP0001440_abnormal_grooming_behavior | 1.22546878 |
| 46 | MP0000049_abnormal_middle_ear | 1.22481537 |
| 47 | MP0001790_abnormal_immune_system | 1.22323524 |
| 48 | MP0005387_immune_system_phenotype | 1.22323524 |
| 49 | MP0009643_abnormal_urine_homeostasis | 1.19852667 |
| 50 | MP0010329_abnormal_lipoprotein_level | 1.18171109 |
| 51 | MP0005410_abnormal_fertilization | 1.08812559 |
| 52 | MP0001501_abnormal_sleep_pattern | 1.06312607 |
| 53 | MP0004019_abnormal_vitamin_homeostasis | 1.02901397 |
| 54 | MP0010155_abnormal_intestine_physiology | 1.02646455 |
| 55 | MP0005310_abnormal_salivary_gland | 0.99722561 |
| 56 | MP0000538_abnormal_urinary_bladder | 0.97886630 |
| 57 | MP0001968_abnormal_touch/_nociception | 0.97271515 |
| 58 | MP0001800_abnormal_humoral_immune | 0.94272987 |
| 59 | MP0005671_abnormal_response_to | 0.94184172 |
| 60 | MP0003252_abnormal_bile_duct | 0.93059962 |
| 61 | MP0000470_abnormal_stomach_morphology | 0.92370169 |
| 62 | MP0004381_abnormal_hair_follicle | 0.91320096 |
| 63 | MP0002272_abnormal_nervous_system | 0.91164725 |
| 64 | MP0002876_abnormal_thyroid_physiology | 0.91130343 |
| 65 | MP0005332_abnormal_amino_acid | 0.91035932 |
| 66 | MP0002095_abnormal_skin_pigmentation | 0.88812898 |
| 67 | MP0004142_abnormal_muscle_tone | 0.88600453 |
| 68 | MP0004484_altered_response_of | 0.88213288 |
| 69 | MP0005266_abnormal_metabolism | 0.88090454 |
| 70 | MP0003787_abnormal_imprinting | 0.87860534 |
| 71 | MP0005174_abnormal_tail_pigmentation | 0.86019354 |
| 72 | MP0001348_abnormal_lacrimal_gland | 0.84491850 |
| 73 | MP0005381_digestive/alimentary_phenotyp | 0.83078520 |
| 74 | MP0002638_abnormal_pupillary_reflex | 0.81810358 |
| 75 | MP0001666_abnormal_nutrient_absorption | 0.81161425 |
| 76 | MP0003195_calcinosis | 0.81090857 |
| 77 | MP0008775_abnormal_heart_ventricle | 0.81029110 |
| 78 | MP0002210_abnormal_sex_determination | 0.80874982 |
| 79 | MP0004742_abnormal_vestibular_system | 0.74704645 |
| 80 | MP0003011_delayed_dark_adaptation | 0.73644061 |
| 81 | MP0009764_decreased_sensitivity_to | 0.73282824 |
| 82 | MP0001293_anophthalmia | 0.72198428 |
| 83 | MP0009745_abnormal_behavioral_response | 0.71981473 |
| 84 | MP0002723_abnormal_immune_serum | 0.71600884 |
| 85 | MP0001756_abnormal_urination | 0.69717747 |
| 86 | MP0008058_abnormal_DNA_repair | 0.69506910 |
| 87 | MP0003045_fibrosis | 0.68912478 |
| 88 | MP0009333_abnormal_splenocyte_physiolog | 0.68566567 |
| 89 | MP0001963_abnormal_hearing_physiology | 0.68253396 |
| 90 | MP0008995_early_reproductive_senescence | 0.67443677 |
| 91 | MP0000230_abnormal_systemic_arterial | 0.67382075 |
| 92 | MP0003183_abnormal_peptide_metabolism | 0.67150817 |
| 93 | MP0001819_abnormal_immune_cell | 0.66174870 |
| 94 | MP0001485_abnormal_pinna_reflex | 0.66106969 |
| 95 | MP0002420_abnormal_adaptive_immunity | 0.65856170 |
| 96 | MP0000678_abnormal_parathyroid_gland | 0.65069006 |
| 97 | MP0002735_abnormal_chemical_nociception | 0.64276583 |
| 98 | MP0003866_abnormal_defecation | 0.63954418 |
| 99 | MP0003786_premature_aging | 0.63477859 |
| 100 | MP0003698_abnormal_male_reproductive | 0.62593942 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoplasia of the fovea (HP:0007750) | 4.36337209 |
| 2 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 4.36337209 |
| 3 | Unilateral renal agenesis (HP:0000122) | 4.08989117 |
| 4 | Bilateral microphthalmos (HP:0007633) | 3.98092953 |
| 5 | Congenital stationary night blindness (HP:0007642) | 3.86111060 |
| 6 | Hip dysplasia (HP:0001385) | 3.66888559 |
| 7 | Abnormality of the fovea (HP:0000493) | 3.48433363 |
| 8 | Molar tooth sign on MRI (HP:0002419) | 3.35963183 |
| 9 | Abnormality of midbrain morphology (HP:0002418) | 3.35963183 |
| 10 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.23470490 |
| 11 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.10467674 |
| 12 | Conjugated hyperbilirubinemia (HP:0002908) | 3.09434239 |
| 13 | 3-Methylglutaconic aciduria (HP:0003535) | 3.02793726 |
| 14 | Pancreatic cysts (HP:0001737) | 2.84869610 |
| 15 | True hermaphroditism (HP:0010459) | 2.81760466 |
| 16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.78701810 |
| 17 | Reticulocytopenia (HP:0001896) | 2.77020791 |
| 18 | Abnormality of the pons (HP:0007361) | 2.75572095 |
| 19 | Hypoplasia of the pons (HP:0012110) | 2.72355490 |
| 20 | Abnormal number of erythroid precursors (HP:0012131) | 2.71129001 |
| 21 | Bile duct proliferation (HP:0001408) | 2.70184870 |
| 22 | Abnormal biliary tract physiology (HP:0012439) | 2.70184870 |
| 23 | Hypoplasia of the uterus (HP:0000013) | 2.70168154 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 2.70049210 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.70049210 |
| 26 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.69839230 |
| 27 | Hyperglycinuria (HP:0003108) | 2.65160453 |
| 28 | Hyperglycinemia (HP:0002154) | 2.64633684 |
| 29 | Fused cervical vertebrae (HP:0002949) | 2.56233496 |
| 30 | Panhypogammaglobulinemia (HP:0003139) | 2.55961428 |
| 31 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.53120707 |
| 32 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.48431505 |
| 33 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.48326721 |
| 34 | Constricted visual fields (HP:0001133) | 2.45484021 |
| 35 | Pancreatic fibrosis (HP:0100732) | 2.45333317 |
| 36 | Posterior subcapsular cataract (HP:0007787) | 2.43755749 |
| 37 | Progressive inability to walk (HP:0002505) | 2.42322685 |
| 38 | Abnormality of the renal cortex (HP:0011035) | 2.41331867 |
| 39 | Decreased central vision (HP:0007663) | 2.40950213 |
| 40 | Aplasia cutis congenita (HP:0001057) | 2.39610563 |
| 41 | Confusion (HP:0001289) | 2.39223541 |
| 42 | Decreased circulating renin level (HP:0003351) | 2.38835520 |
| 43 | Abolished electroretinogram (ERG) (HP:0000550) | 2.37431715 |
| 44 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.35584835 |
| 45 | Tubular atrophy (HP:0000092) | 2.33389495 |
| 46 | Abnormality of the renal collecting system (HP:0004742) | 2.28609719 |
| 47 | Metabolic alkalosis (HP:0200114) | 2.28074566 |
| 48 | Concave nail (HP:0001598) | 2.25057342 |
| 49 | Tachypnea (HP:0002789) | 2.24907016 |
| 50 | Widely patent fontanelles and sutures (HP:0004492) | 2.21369036 |
| 51 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.20818015 |
| 52 | Abnormality of B cell number (HP:0010975) | 2.20653853 |
| 53 | Mixed hearing impairment (HP:0000410) | 2.19929928 |
| 54 | Nephronophthisis (HP:0000090) | 2.19467275 |
| 55 | Asplenia (HP:0001746) | 2.18372107 |
| 56 | Tetraplegia (HP:0002445) | 2.14769789 |
| 57 | Abnormality of urine glucose concentration (HP:0011016) | 2.14295549 |
| 58 | Glycosuria (HP:0003076) | 2.14295549 |
| 59 | Attenuation of retinal blood vessels (HP:0007843) | 2.13825200 |
| 60 | Opisthotonus (HP:0002179) | 2.12475838 |
| 61 | Lipid accumulation in hepatocytes (HP:0006561) | 2.08125075 |
| 62 | Inability to walk (HP:0002540) | 2.06947704 |
| 63 | Macrocytic anemia (HP:0001972) | 2.05257131 |
| 64 | Abnormality of DNA repair (HP:0003254) | 2.04342805 |
| 65 | Abnormality of the right ventricle (HP:0001707) | 2.02579219 |
| 66 | Abnormality of the renal medulla (HP:0100957) | 2.00246864 |
| 67 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.95100713 |
| 68 | Central scotoma (HP:0000603) | 1.92658231 |
| 69 | Male pseudohermaphroditism (HP:0000037) | 1.92486099 |
| 70 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.92213911 |
| 71 | Type II lissencephaly (HP:0007260) | 1.91524402 |
| 72 | B lymphocytopenia (HP:0010976) | 1.90888980 |
| 73 | Bulbous nose (HP:0000414) | 1.90472642 |
| 74 | Triphalangeal thumb (HP:0001199) | 1.90305434 |
| 75 | Increased hepatocellular lipid droplets (HP:0006565) | 1.90019157 |
| 76 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.88687732 |
| 77 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.88687732 |
| 78 | Abnormal protein glycosylation (HP:0012346) | 1.88687732 |
| 79 | Abnormal glycosylation (HP:0012345) | 1.88687732 |
| 80 | Autoimmune thrombocytopenia (HP:0001973) | 1.88057564 |
| 81 | Dyskinesia (HP:0100660) | 1.86188224 |
| 82 | Pallor (HP:0000980) | 1.85229580 |
| 83 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.84950295 |
| 84 | Abnormality of macular pigmentation (HP:0008002) | 1.84428775 |
| 85 | Respiratory difficulties (HP:0002880) | 1.82204437 |
| 86 | Conical tooth (HP:0000698) | 1.81879126 |
| 87 | Lissencephaly (HP:0001339) | 1.81877303 |
| 88 | Reduced antithrombin III activity (HP:0001976) | 1.80236028 |
| 89 | Stomatitis (HP:0010280) | 1.78311639 |
| 90 | CNS hypomyelination (HP:0003429) | 1.76774322 |
| 91 | Alkalosis (HP:0001948) | 1.76564306 |
| 92 | Abnormal drinking behavior (HP:0030082) | 1.75753553 |
| 93 | Polydipsia (HP:0001959) | 1.75753553 |
| 94 | Cystic liver disease (HP:0006706) | 1.72503577 |
| 95 | Increased CSF lactate (HP:0002490) | 1.71527740 |
| 96 | Acute necrotizing encephalopathy (HP:0006965) | 1.71519369 |
| 97 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.71234152 |
| 98 | Optic disc pallor (HP:0000543) | 1.70108413 |
| 99 | IgG deficiency (HP:0004315) | 1.68045677 |
| 100 | Facial hemangioma (HP:0000329) | 1.67415987 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.47347667 |
| 2 | BMPR2 | 3.26566720 |
| 3 | NUAK1 | 3.11579242 |
| 4 | TLK1 | 3.04577131 |
| 5 | ADRBK2 | 3.02462836 |
| 6 | INSRR | 2.72715825 |
| 7 | PINK1 | 2.72337140 |
| 8 | TAOK3 | 2.50045419 |
| 9 | VRK2 | 2.47393283 |
| 10 | ACVR1B | 2.45634408 |
| 11 | CDK19 | 2.39921197 |
| 12 | GRK1 | 2.37885235 |
| 13 | TAF1 | 2.34561896 |
| 14 | TIE1 | 2.27644204 |
| 15 | MAP4K1 | 2.18847461 |
| 16 | TXK | 2.03700522 |
| 17 | MAP4K2 | 1.99544086 |
| 18 | PBK | 1.85823309 |
| 19 | LIMK1 | 1.84382141 |
| 20 | SIK3 | 1.75545144 |
| 21 | RPS6KB2 | 1.73610186 |
| 22 | BMPR1B | 1.60847708 |
| 23 | ZAK | 1.52875825 |
| 24 | NEK2 | 1.48948730 |
| 25 | FRK | 1.48916598 |
| 26 | SIK2 | 1.48125645 |
| 27 | MAPKAPK5 | 1.46679318 |
| 28 | TEC | 1.41815513 |
| 29 | OXSR1 | 1.16166037 |
| 30 | DAPK2 | 1.10261507 |
| 31 | VRK1 | 1.05217591 |
| 32 | SYK | 1.04481043 |
| 33 | WNK4 | 1.02214327 |
| 34 | RPS6KA6 | 0.98379586 |
| 35 | STK3 | 0.97539105 |
| 36 | BTK | 0.94503095 |
| 37 | WNK3 | 0.94173775 |
| 38 | MATK | 0.93982077 |
| 39 | PASK | 0.91192745 |
| 40 | STK38L | 0.90020103 |
| 41 | MARK3 | 0.90013384 |
| 42 | BCKDK | 0.88863944 |
| 43 | FLT3 | 0.85683946 |
| 44 | KIT | 0.85057976 |
| 45 | PIK3CA | 0.85055946 |
| 46 | ERBB2 | 0.84557984 |
| 47 | MAP2K6 | 0.81831883 |
| 48 | STK11 | 0.81694167 |
| 49 | TGFBR1 | 0.80965502 |
| 50 | ITK | 0.80679400 |
| 51 | PRKCG | 0.79692079 |
| 52 | ADRBK1 | 0.77369771 |
| 53 | MAP3K11 | 0.76818152 |
| 54 | RPS6KC1 | 0.76463883 |
| 55 | RPS6KL1 | 0.76463883 |
| 56 | DYRK2 | 0.73210497 |
| 57 | STK39 | 0.71863028 |
| 58 | NME1 | 0.71156816 |
| 59 | MAP3K7 | 0.69913753 |
| 60 | PRKCQ | 0.68874345 |
| 61 | IKBKB | 0.65929365 |
| 62 | STK16 | 0.63547149 |
| 63 | PRKCE | 0.58906232 |
| 64 | MAPK13 | 0.58083737 |
| 65 | EIF2AK3 | 0.56946311 |
| 66 | MAP2K2 | 0.55691602 |
| 67 | PRKCA | 0.55416027 |
| 68 | DAPK1 | 0.55266043 |
| 69 | GRK5 | 0.50967680 |
| 70 | NLK | 0.50259272 |
| 71 | JAK3 | 0.49186494 |
| 72 | MKNK1 | 0.47669545 |
| 73 | PRKD3 | 0.44963004 |
| 74 | IGF1R | 0.44871545 |
| 75 | SMG1 | 0.44682089 |
| 76 | PRKAA2 | 0.44106092 |
| 77 | RPS6KB1 | 0.43324588 |
| 78 | MAP3K4 | 0.42989812 |
| 79 | LCK | 0.42818720 |
| 80 | MAPK4 | 0.42710661 |
| 81 | PLK2 | 0.42287441 |
| 82 | MUSK | 0.41997328 |
| 83 | PLK4 | 0.41724965 |
| 84 | LATS1 | 0.41695919 |
| 85 | MELK | 0.40250362 |
| 86 | CSNK2A1 | 0.39903613 |
| 87 | MAPKAPK3 | 0.39204130 |
| 88 | MYLK | 0.37524285 |
| 89 | CSNK2A2 | 0.37097789 |
| 90 | PLK1 | 0.36754837 |
| 91 | DYRK1A | 0.36597618 |
| 92 | PRKACG | 0.36548479 |
| 93 | LYN | 0.35843836 |
| 94 | PRKACA | 0.34117378 |
| 95 | TRIM28 | 0.32521975 |
| 96 | TNIK | 0.32406784 |
| 97 | RPS6KA5 | 0.31262771 |
| 98 | CSNK1A1 | 0.30416411 |
| 99 | CHEK2 | 0.30308348 |
| 100 | PRKCD | 0.30184094 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 3.90648194 |
| 2 | Sulfur relay system_Homo sapiens_hsa04122 | 3.08305547 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.91330236 |
| 4 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.79090767 |
| 5 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.44343063 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.44071894 |
| 7 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.37391467 |
| 8 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.34349484 |
| 9 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.26821011 |
| 10 | Asthma_Homo sapiens_hsa05310 | 2.14600355 |
| 11 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.07637870 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 2.00904557 |
| 13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.97865802 |
| 14 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.91996077 |
| 15 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.87244460 |
| 16 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.79567534 |
| 17 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.75347941 |
| 18 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.68388423 |
| 19 | Retinol metabolism_Homo sapiens_hsa00830 | 1.60238513 |
| 20 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.59352702 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.57594604 |
| 22 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.51569353 |
| 23 | Phototransduction_Homo sapiens_hsa04744 | 1.46851407 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.44320314 |
| 25 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.44205484 |
| 26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.37732494 |
| 27 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.37335581 |
| 28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.35884600 |
| 29 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.33805709 |
| 30 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.29146057 |
| 31 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.28744671 |
| 32 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.26465393 |
| 33 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.25184789 |
| 34 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.21861013 |
| 35 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.21711310 |
| 36 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.19741369 |
| 37 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.18180869 |
| 38 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.17920731 |
| 39 | Peroxisome_Homo sapiens_hsa04146 | 1.16585029 |
| 40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.11504343 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.10978860 |
| 42 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.10877132 |
| 43 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.09064833 |
| 44 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.08916390 |
| 45 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.08329803 |
| 46 | RNA degradation_Homo sapiens_hsa03018 | 1.07906800 |
| 47 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.05899592 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.05153657 |
| 49 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.02455942 |
| 50 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.99544920 |
| 51 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.98378891 |
| 52 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.97484391 |
| 53 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.95165044 |
| 54 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.88620177 |
| 55 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.88348900 |
| 56 | RNA polymerase_Homo sapiens_hsa03020 | 0.87819460 |
| 57 | Histidine metabolism_Homo sapiens_hsa00340 | 0.84966579 |
| 58 | Salivary secretion_Homo sapiens_hsa04970 | 0.82964306 |
| 59 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.76833483 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 0.74701763 |
| 61 | Taste transduction_Homo sapiens_hsa04742 | 0.74631842 |
| 62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.74537598 |
| 63 | Basal transcription factors_Homo sapiens_hsa03022 | 0.73252219 |
| 64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70305542 |
| 65 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.67688636 |
| 66 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.67452312 |
| 67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66247796 |
| 68 | Homologous recombination_Homo sapiens_hsa03440 | 0.65720881 |
| 69 | Purine metabolism_Homo sapiens_hsa00230 | 0.65117879 |
| 70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.64905060 |
| 71 | Mineral absorption_Homo sapiens_hsa04978 | 0.63503197 |
| 72 | Long-term depression_Homo sapiens_hsa04730 | 0.63357310 |
| 73 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.60363757 |
| 74 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.58728740 |
| 75 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.52500329 |
| 76 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.52230515 |
| 77 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.50256377 |
| 78 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.50195439 |
| 79 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.49491845 |
| 80 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.48686637 |
| 81 | Insulin secretion_Homo sapiens_hsa04911 | 0.48151540 |
| 82 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.47203218 |
| 83 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47143261 |
| 84 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.47002189 |
| 85 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.46300044 |
| 86 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.46081188 |
| 87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.46032356 |
| 88 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.45636876 |
| 89 | Nicotine addiction_Homo sapiens_hsa05033 | 0.44083407 |
| 90 | Base excision repair_Homo sapiens_hsa03410 | 0.43482816 |
| 91 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.41886932 |
| 92 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.41647033 |
| 93 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.41510709 |
| 94 | Parkinsons disease_Homo sapiens_hsa05012 | 0.41105638 |
| 95 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.38147932 |
| 96 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.37362990 |
| 97 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.36670458 |
| 98 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.36329888 |
| 99 | Morphine addiction_Homo sapiens_hsa05032 | 0.36261596 |
| 100 | Alzheimers disease_Homo sapiens_hsa05010 | 0.34329115 |

